Form 4/A for VMD VIEMED HEALTHCARE, INC.
Accepted 2023-01-20 00:00:00 ET · period of report 2023-01-17 · accession 0001729149-23-000025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2023-01-20 | 2023-01-18 | VMD | Cambre Jerome | VP of Sales | M - OptEx | — | +7,808 | 65.8K | +13% | — |
| DA | 2023-01-20 | 2023-01-18 | VMD | Cambre Jerome | VP of Sales | F - Tax | $7.77 | -1,713 | 65.9K | -3% | -$13.3K |
| DA | 2023-01-20 | 2023-01-18 | VMD | Cambre Jerome | VP of Sales | D - Sale to Iss | $7.77 | -3,003 | 62.8K | -5% | -$23.3K |
| DMA | 2023-01-20 | 2023-01-17 | VMD | Cambre Jerome | VP of Sales | A - Grant | $0.00 | +32.0K | 25.6K | New | $0 |
| DMA | 2023-01-20 | 2023-01-18 | VMD | Cambre Jerome | VP of Sales | M - OptEx | $0.00 | -7,808 | 9,609 | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-01-18 | M | A | 4,805 | — | 67,593 | D | — | — | (F3) Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. |
| 2 | Common | Common Shares | 2023-01-18 | M | A | 3,003 | — | 65,791 | D | — | — | (F1) Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. |
| 3 | Common | Common Shares | 2023-01-18 | F | D | 1,713 | $7.77 | 65,880 | D | — | — | (F4) On January 18, 2023, the reporting person filed a timely Form 4 which omitted the withholding of shares to satisfy tax obligations due to timing differences in the processing of awards. This amendment includes the timely reporting of tax related withholding of shares associated with vestings of awards previously reported on this form. (F2) Per share value is based on the market closing price of the common shares for January 18, 2023. |
| 4 | Common | Common Shares | 2023-01-18 | D | D | 3,003 | $7.77 | 62,788 | D | — | — | (F2) Per share value is based on the market closing price of the common shares for January 18, 2023. |
| 5 | Derivative | Phantom Share Units | 2023-01-17 | A | A | 6,394 | $0.00 | 6,394 | D | — · — to 2026-01-17 | 6,394 Common Shares | (F7) Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. (F8) Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. |
| 6 | Derivative | Phantom Share Units | 2023-01-18 | M | D | 3,003 | $0.00 | 6,006 | D | — · — to 2025-01-18 | 3,003 Common Shares | (F1) Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. (F5) Represents an award granted on January 18, 2022 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. |
| 7 | Derivative | Restricted Stock Units | 2023-01-18 | M | D | 4,805 | $0.00 | 9,609 | D | — · — to 2025-01-18 | 4,805 Common Shares | (F3) Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. (F6) Restricted Stock Units (RSUs) granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date. |
| 8 | Derivative | Restricted Stock Units | 2023-01-17 | A | A | 25,575 | $0.00 | 25,575 | D | — · — to 2026-01-17 | 25,575 Common Shares | (F3) Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. (F9) Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date. |